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ABSTRACT 
 
Background: Advanced chronic kidney disease (CKD) is associated with the 
development of renal metabolic acidosis. Metabolic acidosis per se may 
represent a trigger for progression of CKD. Renal acidosis of CKD is 
characterized by low urinary ammonium excretion with preserved urinary 
acidification indicating a defect in renal ammoniagenesis, ammonia excretion or 
both. The underlying molecular mechanisms, however, have not been addressed 
to date.  
Methods: We examined the Han:SPRD rat model and used a combination of 
metabolic studies, mRNA and protein analysis of renal molecules involved in 
acid-base handling. 
Results: We demonstrate that rats with reduced kidney function as evident from 
lower creatinine clearance, lower hematocrit, higher plasma BUN, creatinine, 
phosphate and potassium, had metabolic acidosis that could be aggravated by 
HCl acid loading. Urinary ammonium excretion was highly reduced whereas 
urinary pH was more acidic in CKD compared to control animals. The abundance 
of key enzymes and transporters of proximal tubular ammoniagenesis (PDG, 
PEPCK, SNAT3) and bicarbonate transport (NBCe1) was reduced in CKD 
compared to control animals. In the collecting duct, normal expression of the B1 
H+-ATPase subunit is in agreement with low urinary pH. In contrast, the RhCG 
ammonia transporter, critical for the final secretion of ammonia into urine was 
strongly downregulated in CKD animals.  
Impaired ammonium excretion in CKD 
3 
 
Conclusion: In the Han.SPRD rat model for CKD key molecules required for 
renal ammoniagenesis and ammonia excretion are highly downregulated 
providing a possible molecular explanation for the development and maintenance 
of renal acidosis in CKD patients. 
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INTRODUCTION 
Metabolic acidosis is frequent in chronic kidney disease (CKD) and is 
associated with several complications such as muscle wasting, impaired growth 
in children, bone disease, hypo-albuminemia, inflammation, and insulin 
resistance. Moreover it has been associated with increased mortality in dialysis 
and non-dialysis dependent CKD patients [1-5]. Numerous recent studies 
particularly highlighted the role of metabolic acidosis in the progression of CKD 
and the increased risk to develop end stage renal disease [6-9]. The mechanisms 
of metabolic acidosis in CKD have been first functionally investigated more than 
50 years ago and it was shown that patients with metabolic acidosis and CKD 
demonstrate reduced excretion of ammonium, the most important buffer for renal 
acid excretion and bicarbonate synthesis, with preserved ability to acidify urine 
[10-13]. However, the affected molecular pathways in the development of 
metabolic acidosis in CKD have not been addressed to date.  
Hannover rat (Han:SPRD) is a commonly used model for autosomal 
dominant polycystic kidney disease although the disease is caused by a mutation 
in the Pkdr1 gene and no mutations are found in humans with polycystic kidney 
disease (3, 4). Heterozygous male (cy/+) animals are characterized by a slow 
progression of kidney disease and proteinuria [14, 15]. Consequently, these rats 
have also been used as a model for chronic kidney disease [16, 17]. 
  
Renal ammoniagenesis and ammonium excretion depend on a complex 
interplay between different nephron segments [18-21]. Ammoniagenesis in the 
proximal tubule serves mostly the de novo synthesis of bicarbonate to replenish 
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bicarbonate buffers used by metabolism. Glutamine is taken up by proximal 
tubule cells, most likely by the SNAT3 amino acid transporter and metabolized by 
a series of enzymes located in mitochondria and cytosol. Phosphate-dependent 
glutaminase (PDG) and glutamate dehydrogenase (GDH) release two ammonia 
(NH3) molecules and one bicarbonate (HCO3-) ion whereas further metabolism of 
the resulting alpha-ketoglutarate by the phospho-enol pyruvate carboxy kinase 
(PEPCK) generates an additional HCO3- ion. The process of proximal tubular 
ammoniagenesis is highly stimulated during acidosis or by acid-load [21, 22]. 
Ammonium (NH4+) produced by the proximal tubule is mostly released into urine 
and is partly reabsorbed at the level of the thick ascending limb of the loop of 
Henle, concentrated in the medullary interstitium and secreted into urine [18-20]. 
The final secretory step depends on the capacity of H+-ATPases to acidify urine 
and the RhCG ammonia transporter [18, 19, 23].  
 
Here, we used the Han:SPRD rats as a CKD model and investigated the 
regulation of key molecules in renal acid-base handling to identify the molecular 
mechanisms that contribute to the development of metabolic acidosis in chronic 
kidney disease. Our data demonstrate a strongly reduced expression of enzymes 
and transporters involved in proximal ammoniagenesis and ammonia secretion 
whereas the capacity to acidify urine was preserved. Thus, our data suggest that 
metabolic acidosis is caused by the kidneys’ impaired ability to produce and 
excrete adequate ammonium amounts thereby impairing bicarbonate synthesis 
and metabolic acid buffering. 
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MATERIALS AND METHODS 
 
Animal Model 
 The study was conducted in 4 months old male heterozygous (cy/+) and 
wild type (+/+) littermate Han:SPRD rats. Rats received standard diet (Provimi 
Kliba S.A., Switzerland) at day 1 and 2, and consecutively HCl diet (500 g 
standard diet mixed with 750 ml of 333 mM HCl) to induce an additional acid-
loador wet standard diet (analogously mixed with distilled water) for 2 days (days 
3 and 4). Rats were placed into metabolic cages on day 1 for adaptation. Water 
and food intake as well as body weight were daily measured, and 24h-urine 
(under mineral oil) and stool were collected. All animal experiments were 
performed according to national and international guidelines and laws of animal 
welfare and protocols approved by the local Veterinary Authority (Veterinäramt 
Zürich). At the end of the experiments rats were anesthetized with isoflurane, 
heparinized blood was collected from the tail artery, and animals were perfused 
with PBS (136.9 mM NaCl, 2.68 mM KCl, 10 mM Na2HPO4, 1.76 mM KH2PO4, 
pH 7.4 with HCl) to remove blood. Kidneys were immediately removed and 
subsequently snap-frozen in liquid nitrogen and stored at -80°C until further 
analysis. 
 
Blood and Urine Analysis 
 Rats were anesthetized with isoflurane (IsoFlo®, Abbott AG, Baar, 
Switzerland), 1.5 – 2.0 %, and heparinized blood was collected from the tail 
artery and analyzed immediately for pH, blood gases, and electrolytes on a 
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Radiometer ABL 800 Flex blood gas analyzer (Radiometer, Copenhagen, 
Denmark) on day 2,  3 and 5. In addition, at the end of the experiment (day 5) 
blood was taken from the left ventricle and the inferior caval vein to measure 
plasma creatinine, phosphate, BUN, glucose, and albumin using the clinical 
chemistry analyzer Piccolo® Xpress (Abaxis, Union City, CA). Ion 
chromatography (Metrohm ion chromatograph, Herisau, Switzerland) was 
performed to determine urinary Na+, K+, and Cl- concentrations. Urine pH, pCO2, 
and calculated HCO3- were determined by aspirating urine from the collectors 
into gas-tight syringes and injecting it into the blood gas analyzer. Urinary 
creatinine was analyzed using the Jaffé method [24, 25]. Urinary ammonium 
concentration was determined using the Berthelot protocol [26]. Urinary 
phosphate was measured by standards of Urine Precision Controls (Randox 
Lab., UK). Creatinine clearance was calculated from the measured values. 
 
RNA extraction 
 Approximately 25 mg of snap-frozen kidney tissue was homogenized in 
RLT-Buffer (Qiagen, Hilden, Germany) supplemented with 2-mercaptoethanol to 
a final concentration of 1 %. Total RNA was extracted from 600 μl of each 
homogenized sample using the RNeasy Mini Kit (Qiagen) according to the 
manufacturer’s instructions. DNase digestion was performed using the RNase-
Free DNase Set (Qiagen). Quality, purity, and concentration of the isolated RNA 
preparations were analyzed spectroscopically using the ND-1000 
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spectrophotometer (NanoDrop Technologies, Wilmington, DE). Total RNA 
samples were stored at – 80 °C.  
 
Semi-quantitative real-time RT-PCR 
 The RNA samples were diluted to 100 ng/μl. First, reverse transcription 
was performed using the TaqMan Reverse Transcription Reagents (Roche 
Molecular Systems, Branchburg, NJ/Applied Biosystems). Briefly, 12.4 μl RNase-
free water, 4 μl 10X RT Buffer, 8.8 μl MgCl2 Solution, 2 μl Random Hexamers, 8 
μl dNTP Mixture, 0.8 μl RNase Inhibitor, and 1 μl MultiScribe Reverse 
Transcriptase (respectively 1 μl of additional RNase-free water for negative 
controls) were mixed with 3 μl of RNA to perform reverse transcription by using 
the Tpersonal Combi thermocycler (Biometra, Göttingen, Germany) with 
thermocycling conditions set at 25 °C for 10 min, 48 °C for 30 min, and 95 °C for 
5 min. Next, relative mRNA expression was determined using quantitative real-
time PCR (qRT-PCR) with the 7500 Fast Real-Time PCR System (Applied 
Biosystems) on the basis of the standard 7500 run mode. Primers for all genes of 
interest were designed using Primer3-web software (frodo.wi.mit.edu/primer3) 
(see supplementary table 1). Probes of the tested genes were labeled with the 
reporter dye FAM at the 5’ end and the quencher dye TAMRA at the 3’ end 
(Microsynth, Balgach, Switzerland). The probe of the housekeeping gene Human 
18S rRNA (Applied Biosystems, Foster City, CA) was labeled with the reporter 
dye VIC at the 5’ end and the quencher dye TAMRA at the 3’ end. The specificity 
of all primers was first tested in a standard PCR and always resulted in a single 
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product of the expected size on 1.5 % agarose gels (data not shown). Briefly, 2 μl 
cDNA, 0.8 μl of each primer (25 μM), 0.4 μl labeled probe (5 μM), 6 μl RNase-
free water, and 10 μl TaqMan Universal PCR Master Mix (Applied Biosystems) 
reached 20 μl of final reaction volume for the tested gene. The protocol for the 
housekeeping gene was slightly different as the following: 2 μl cDNA, 1 μl of the 
Human 18S rRNA (20X) Control primers and probe reagent, 7 μl RNase-free 
water, and 10 μl TaqMan Universal PCR Master Mix. Reaction conditions were: 
Denaturation at 95 °C for 10 min followed by 40 cycles of denaturation at 95 °C 
for 15 s and annealing/elongation at 60 °C for 60 s with autoramp time. All 
reactions were run in triplicates, including a negative control. To analyze the 
data, we set the threshold to 0.06 as this value had been determined to be in the 
linear range of the amplification curves for all mRNAs in all experimental runs. 
The expression of gene of interest was calculated in relation to Human 18S 
rRNA. Relative expression ratios were calculated as R = 2[Ct(18S)-Ct(gene of interest)], 
where Ct represents the cycle number at the threshold 0.06. 
 
Western Immunoblotting 
 For immunoblotting brush border membrane (BBM) proteins were 
prepared using the Mg2+ precipitation technique [27]. Additionally, protein 
extraction of total membrane fractions (MF) of kidney tissue was performed. 
Briefly, kidney tissue was homogenized in ice-cold HEPES buffer (200 mM 
mannitol, 80 mM HEPES, 41 mM KOH, titrated with KOH to pH 7.5) with 
Protease Inhibitors Cocktail Tablets complete, Mini (Roche Diagnostics GmbH, 
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Mannheim, Germany). Both BBM and MF protein samples were used for 
Western Blotting. After measurement of the protein concentration (Bio-Rad Dc 
Protein Assay, Bio-Rad, Hercules, CA), 40 μg of MF protein or 20 μg of BBM 
protein was solubilized in Laemmli sample buffer, and SDS-PAGE was 
performed on 8 – 10 % polyacrylamide gels. Proteins were transferred 
electrophoretically from gels to polyvinylidene difluoride membranes (Immobilon-
P, Millipore, Bedford, MA). After blocking with 5 % milk powder in Tris-buffered 
saline containing 0.1 % (v/v) Tween-20 for 60 min at room temperature, the blots 
were incubated with the respective primary antibodies overnight at 4 °C or 2 h at 
room temperature (see supplementary table 2). Antibodies against SNAT 
produced two bands, a specific band of approximately 55-60 kDa and an 
unspecific band of lower molecular weight of approximately 40 kDa. PDG 
appears as two bands of 66 and 68 kDa and both bands were quantified together 
[28]. Similarly, pendrin antibodies recognized two specific bands of approximately 
100 and 150 kDa [29]. 
 
After washing and subsequent blocking, blots were incubated with the secondary 
antibody [donkey anti-rabbit or sheep anti-mouse antibodies linked to horseradish 
peroxidase 1:10,000 (GE Healthcare, Little Chalfont, Buckinghamshire, UK) or 
goat anti-rabbit and goat anti-mouse antibody 1:5,000 linked to alkaline 
phosphatase (Promega, Madison, WI) for 1 h at room temperature. Antibody 
binding was detected with appropriate Immobilon Western chemiluminescence 
substrates (Millipore, Billerica, MA), using the LAS-4000 Luminescent Image 
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Analyzer (Fujifilm, Tokyo, Japan). All images were analyzed using appropriate 
software (Advanced Image Data Analyzer version 3.44, Raytest) to calculate the 
protein of interest/actin ratio. 
 
 
Statistical Analysis 
 All data are presented as means ± SE. Unpaired two-tailed t-test or 
ANOVA with Bonferroni correction were applied for inference statistics and result 
with p-value < 0.05 were considered statistically significant.  
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RESULTS 
 
Han:SPRD cy/+ rats recapitulate hallmarks of chronic kidney disease and 
develop severe hyperchloremic metabolic acidosis 
 Cy/+ compared to +/+ rats receiving standard diet had lower blood 
bicarbonate, higher chloride, and reduced pCO2 levels indicating a partly 
compensated hyperchloremic metabolic acidosis. Potassium and phosphate 
plasma levels were elevated and creatinine clearance and hematocrit were lower 
demonstrating advanced chronic kidney disease (tables 1 and 2) in cy/+ rats. 
Urine analysis showed more acidic urine, lower urinary bicarbonate, and higher 
phosphate excretion in cy/+ compared to +/+ rats whereas ammonium excretion 
was similar between groups (table 2). Thus, cy/+ rats display the major hallmarks 
of advanced chronic kidney disease confirming and expanding previous reports 
[30, 31].   
 
 Next we tested the rats ability to respond to an additional acid load 
administrated by adding HCl to food for 48 hrs. Arterial blood gas analysis 
confirmed induction of metabolic acidosis in HCl-treated animals (table 1). 
However, cy/+ rats developed a more severe metabolic acidosis compared to +/+ 
littermates (blood pH 7.13 ± 0.00 vs. 7.34 ± 0.01). Accordingly, arterial 
bicarbonate levels were lower in cy/+ animals compared to +/+ rats (8.3 ± 0.4 vs. 
15.6 ± 0.3 mmol/l). These results indicate, that cy/+ animals’ ability to buffer an 
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acid load is impaired. Interestingly, induction of acidosis was associated with a 
fall in creatinine clearance in both wildtype and cy/+ animals (table 2). 
 The dietary acid load caused a markedly acidic urinary pH in both cy/+ 
and +/+ rats (table 2). Thus, also cy/+ rats with markedly reduced renal function 
were able to acidify urine to the same extent as wildtype animals with normal 
renal function. Similar, patients with advanced CKD maintain their ability to 
acidify urine [10, 12] suggesting that the Han:SPRD rat model serves as an 
useful CKD model for studying metabolic acidosis.  
After acid load urinary ammonium excretion, a major component of overall net 
acid excretion, was significantly lower in cy/+ compared to +/+ rats (table 2) 
whereas, urinary phosphate excretion, a major component of titratable acidity, 
increased modestly in both animal groups. Our data suggest that urinary 
acidification is preserved in CKD animals whereas urinary ammonium excretion 
is decreased by approximately 60 – 80 % which is paralleled by more severe 
metabolic acidosis. 
  
Expression of ammoniagenic key molecules is reduced in CKD rats 
 We performed real-time RT-qPCR on kidney tissue for SNAT3, PDG, 
PEPCK, and the sodium/proton exchanger type 3 (NHE3), key molecules of the 
renal ammoniagenesis pathway. The mRNA abundance of PEPCK, SNAT3, and 
NHE3 was reduced in cy/+ CKD rats (figure 1) compared to wildtype animals 
under standard diet and after 48 hrs acid load. In contrast, PDG mRNA 
expression was increased after the acid load in cy/+CKD animals (figure 1).  
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Similarly protein abundance of SNAT3 and PEPCK in cy/+animals was markedly 
decreased compared to wildtype littermates (figure 2). PDG protein levels were 
decreased after the acid load, opposite to mRNA levels (figure 2). Protein levels 
of NHE3 were not different compared to wildtype animals (figure 2). 
 The electrogenic sodium/bicarbonate cotransporter type 1 (NBCe1) is 
located on the basolateral membrane of the proximal tubule cell and releases 
bicarbonate into blood. mRNA expression of NBCe1 was decreased in cy/+ CKD 
animals under standard diet and increased after acid load (figure 3). Protein 
levels were also decreased under both standard diet and after the acid load 
(figure 3).  
 Taken together, these data demonstrate a strong reduction in the 
expression of key molecules of the ammoniagenesis pathway in kidneys from 
cy/+ CKD animals under standard diet.  CKD animals were able to modestly 
increase urinary ammonium excretion after acid loading, however, to a much 
lesser extent than wildtype animals. Thus, reduced expression of key molecules 
of the ammoniagenesis pathway parallels lower urinary ammonium excretion in 
CKD rats.   
 
Sodium-dependent phosphate transporters are altered in CKD rats 
 The major renal phosphate transporters NaPi-IIa and NaPi-IIc and the 
third sodium-dependent phosphate transporter Pit-2 are expressed on the apical 
membrane of the proximal tubule cells and mediate phosphate reabsorption [32]. 
mRNA abundance of NaPi-IIa and NaPi-IIc was decreased during standard diet 
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and after acid loading in cy/+ rats compared to control rats (figure 4) while Pit-2 
mRNA expression was not altered. Brush border membrane protein levels of the 
three phosphate transporters were differently regulated. NaPi-IIc protein 
abundance was decreased while NaPi-IIa and Pit.2 remained unchanged. 
However, after an acid load Pit-2 protein levels were increased (figure 5).  
 
Ammonium excretion is reduced in CKD rats 
 The last set of experiments examined the abundance of proteins 
contributing to final urinary acidification and ammonium excretion along the 
collecting duct system: the type A intercalated cell specific AE1 anion exchanger, 
the non-type A intercalated cell marker pendrin, the ammonia transporter RhCG, 
and the B1 subunit of the H+-ATPase enriched in intercalated cells [23].  The 
mRNA abundance of AE1 was decreased in CKD animals while B1 mRNA 
abundance was markedly increased after acid loading compared to wildtype 
animals (figure 6). RhCG and pendrin mRNA abundance was not different. AE1 
protein levels were reduced in CKD rats while B1 protein levels were unchanged 
in comparison to wildtype rats (figure 7).  RhCG protein abundance was strongly 
decreased under standard diet and after acid loading compared to wildtype 
animals. Thus, normal H+-ATPase expression and reduced RhCG abundance 
are consistent with the preserved urinary acidification and reduced ammonium 
excretion in CKD rats.  
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DISCUSSION 
Metabolic acidosis is a common complication of CKD and is associated 
with increased mortality in dialysis and non-dialysis dependent CKD patients. 
Particularly, the impact of metabolic acidosis on the progression of CKD and the 
increased risk to develop end stage renal disease have been recently highlighted 
by studies investigating the effect of alkali supplementation as a potential 
nephroprotective treatment in patients with CKD (5,11,14).  
 
The major findings in our study are: i) cy/+ Han:SPRD rats mimic major 
features of CKD, ii) metabolic acidosis in this CKD rat model is paralleled by the 
reduced expression of key molecules of proximal tubular ammoniagenesis, iii) 
urinary acidification and expression of H+-ATPases in the collecting duct are 
preserved, iv) the RhCG ammonia transporter required for final urinary excretion 
of ammonium is downregulated, and v) renal phosphate reabsorption was 
reduced in CKD rats.  
 
Han:SPRD rats mimic features of chronic kidney disease 
Humans with CKD have reduced GFR and develop several complications 
such as anemia, metabolic acidosis, mineral bone disease, neuropathy etc. with 
progressive disease [33]. Similarly, cy/+ rats presented with chronic kidney 
disease confirmed by elevated creatinine and BUN values in blood and reduced 
creatinine clearance. Cy/+ rats had also metabolic acidosis, lower hematocrit, 
hyperkalemia and hyperphosphatemia. These findings are consistent with and 
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expand previous reports using this rat strain as model for CKD or polycystic 
kidney disease [30, 31]. Acid loading wildtype and cy/+ rats, caused a fall in 
creatinine clearance in both groups. The mechanism(s) by which acidosis may 
reduce GFR is currently not exactly known. 
 
Metabolic acidosis in chronic kidney disease is due to reduced expression of key 
molecules of ammoniagenesis and decreased ammonium excretion by the 
kidney 
Patients with CKD and metabolic acidosis maintain their ability to excrete 
acidic urine but have a reduced capacity to increase their ammonium excretion 
[11, 12].  Ammoniagenesis is markedly reduced in patients with CKD which 
correlates with decreased renal metabolism of glutamine [34]. However, whether 
reduced total ammoniagenesis reflects only a lower number of nephrons or a 
decreased capacity of surviving nephrons has been intensively studied in rat 
models of partial nephrectomy or infarction [13, 35]. These experiments indicated 
that the kidneys capacity to produce ammonium was proportional to nephron 
number, ammoniagenesis could be stimulated by diet and that a compensatory 
increase in ammonium producing cells could be found. In our experiments urinary 
ammonium excretion was inappropriately low in CKD rats and responded only 
with a small increase to the acid load. This may result from impaired 
ammoniagenesis, defective ammonium excretion or urinary acidification, or a 
combination of these factors. mRNA abundance and protein expression of 
PEPCK and SNAT3 were highly reduced in CKD rats. Additionally, PDG and 
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NBCe1 protein abundance were also decreased in acid-loaded CKD rats. Of 
note, the direction of changes in mRNA expression and protein abundance 
differed for NHE3, PDG, NBCe1, NaPi-IIa, and Pit-2 for some conditions. The 
causes for these differences are currently not known but these differences 
indicate that the interpretation of changes in mRNA expression without analysis 
of protein abundance can be misleading. 
SNAT3 is expressed on the basolateral membrane of proximal tubule cells 
mediating glutamine uptake for ammoniagenesis [36-38]. Glutamine is further 
metabolized by a series of enzymes including phosphate dependent glutamine 
(PDG), glutamate dehydrogenase (GDH), and finally phosphoenol pyruvate 
carboxy kinase (PEPCK) resulting in the cumulative synthesis of two NH3 and two 
HCO3- ions [21]. Bicarbonate generated during these metabolic steps is released 
into blood by the basolaterally located NBCe1 sodium-bicarbonate cotransporter. 
Reduced expression of all these key molecules in the cy/+CKD rats may severely 
impair ammoniagenesis and bicarbonate transport.  
We and others have previously shown that many of these transporters and 
enzymes investigated here respond with changes in their expression to 
endogenous or exogenous acid loads. The expression of NHE3, NaPi-IIa, PDG, 
PEPCK, SNAT3, NBCe1, RhCG, and AE1 is increased whereas pendrin 
expression decreased in kidneys from acid-loaded kidneys [39-42].  Here, we 
compared only control animals vs cy/+CKD rats as we wanted to assess how 
renal impairment impacted on the ability of the kidney to excrete acid but were 
not interested to study the renal response per se to an acid load. However, the 
Impaired ammonium excretion in CKD 
19 
 
regulation can be inferred from the ratios between WT and Cy/+ CKD animals at 
baseline and after the acid load showing that most proteins were upregulated in 
the Cy/+ CKD rats with the acid load as the ratios remain constant, e.g. for 
SNAT3, NHE3, NBCe1, NaPi-IIa, NaPi-IIc, AE1, B1, and RhCG. In the case of 
pendrin, acid-loading reduced pendrin expression in WT to the same level as in 
Cy/+ under baseline conditions most likely reflecting the already existing acidosis 
in CKD rats. In contrast, acid-loading revealed a strong increase in Pit-2 
expression in CKD rats and reversed a trend to higher expression of PDG in CKD 
rats to a lower expression in acid-loaded CKD rats. 
We assessed the abundance of these molecules in tissue homogenates 
from whole kidneys. Thus, our results do not directly indicate whether reduced 
abundance is due to reduced nephron number or rather due to decreased 
expression per nephron. Data from animal models with reduced kidney mass 
suggested that the reduced number of functional nephrons would decrease the 
total capacity to produce ammonium and that the rate of ammoniagenesis was 
even stimulated at the level of the single nephron [13, 35]. However, our results 
may be also interpreted as a downregulation of key molecules of 
ammoniagenesis. Reduced expression was found only for few molecules such as 
SNAT3, PEPCK, NBCe1 and NaPi-IIc whereas other proximal tubule proteins 
such as NaPi-IIa, Pit2, NHE3, or PDG remained unaltered or were even up-
regulated. Therefore, the results may suggest that reduced expression of SNAT3, 
PEPCK, and NBCe1 may be caused by a downregulation in surviving nephrons. 
In fact, the degree of metabolic acidosis found in CKD rats at baseline would 
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cause a strong upregulation of these enzymes and transporters in the healthy 
kidney [22]. The mechanisms that may induce a specific downregulation of some 
proximal tubular proteins involved in ammoniagensis and bicarbonate transport 
remain to be identified. Clearly, this important question warrants further 
experiments in this CKD animal model as well as in additional models to clarify 
the underlying mechanisms and whether these mechanisms are model specific 
or occur in different models of CKD and also in humans. 
 
Accumulation of ammonium in the medullary interstitium is necessary to 
facilitate excretion into the collecting duct. The transport of ammonium into the 
interstitium is mediated by the Na+/K+/2Cl- -cotransporter NKCC2 and the Na+/H+ 
exchanger NHE4 and may involve interactions with sulfatides [18, 43, 44]. We 
tested the expression of NKCC2 and found no differences between control and 
Cy/+ CKD rats (data not shown). However, we cannot rule out that expression of 
NHE4 (for which no specific antibodies exist) or the interstitial concentration of 
ammonium were not altered.  
Ammonium excretion and final urinary acidification are mediated by the 
late distal convoluted tubule, connecting tubule, and collecting duct [23]. Type A 
intercalated cells secrete protons and ammonia whereas neighboring segment-
specific cells (principal cells) also contribute to ammonia secretion [19, 23, 45]. 
The final step of ammonia excretion depends on the generation of a cortico-
papillary gradient of ammonia from interstitium into the lumen of the collecting 
duct [20, 43].  Ammonia secretion is mediated by the two rhesus proteins RhBG 
Impaired ammonium excretion in CKD 
21 
 
and RhCG where RhCG appears to play a major role [45, 46]. The driving force 
for ammonia secretion, however, depends on the degree of urinary acidification 
by type A intercalated cells. The importance of acid-base transport proteins in 
these cells is highlighted by inherited disorders in humans with mutations in the 
AE1/SLC4A1 chloride/bicarbonate exchanger, and the B1/ATP6V1B1 and 
a4/ATP6V0A4 H+-ATPase subunits [47-50]. Urinary pH was more acidic in cy/+ 
CKD rats under baseline conditions and was further acidified after the HCl diet 
demonstrating an intact capacity to generate and maintain a steep proton 
gradient from interstitium to the collecting duct lumen. Surprisingly, AE1 mRNA 
and protein abundance was decreased in CKD animals  whereas the abundance 
of the B1 H+-ATPase subunit remained unaltered. Thus, the maximal capacity of 
the collecting duct to maximally acidify urine may be decreased, however, in the 
presence of greatly reduced ammonia concentrations urinary pH remains very 
acidic. The reduced expression of pendrin, a marker of non-type A intercalated 
cells is most likely caused by metabolic acidosis [29, 51, 52]. Impaired ammonia 
secretion by the collecting duct may not only be the result of decreased proximal 
tubular ammoniagenesis but also due to lower expression of the ammonia 
transporter RhCG.  Thus, reduced secretion of ammonia by the collecting duct is 
likely by a combination of decreased ammoniagenesis and reduced RhCG 
expression. The reason for lower RhCG expression is not known and may be 
either the direct consequence of renal disease or a response to reduced 
ammoniagenesis. Similarly, in a mouse model with haploinsufficiency of Rhcg, 
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reduced urinary acid excretion was observed indicating that low levels of RhCG 
expression per se may reduce renal acid excretion [45].  
 
Renal reabsorption of phosphate is reduced in HAN:SPRD rats  
Efficient proton secretion depends in part on the availability of titratable 
acids, mostly phosphate, that buffer protons and thereby prevent an excessive 
urinary acidification that would impair further acid excretion (23). In metabolic 
acidosis phosphate excretion is increased to increase buffer capacity and to 
reduce extracellular phosphate derived from bone [53]. Phosphate excretion in 
the kidney is mainly controlled by reabsorption of phosphate in the proximal 
tubule mediated by a set of sodium dependent transporter, namely NaPi-IIa and 
NaPi-IIc [32]. Protein abundance of NaPi-IIc but not of NaPi-IIa was down-
regulated in CKD rats after HCl load. Urinary phosphate excretion was higher 
after acid loading. Moreover, CKD rats had increased phosphaturia under normal 
conditions that was paralleled by reduced expression of NaPi-IIc but not NaPi-IIa. 
Thus, phosphaturia under these conditions may result from a combination of 
direct inhibition of NaPi-IIa and NaPi-IIc transport activity by lower urinary pH in 
the proximal tubule due to lower plasma bicarbonate levels and the 
downregulation of NaPi-IIc [39]. The upregulation of Pit-2 abundance in acid-
loaded cy/+ rats may reflect a compensatory mechanism to limit urinary 
phosphate losses. 
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In conclusion, we demonstrated that renal ammonium excretion is 
severely impaired in a CKD rat model while urinary acidification is mostly 
preserved. The expression of key molecules of the ammoniagenesis pathway in 
the proximal tubule and the excretory ammonium transporter RhCG is reduced in 
kidney. Whether the reduced number of functional nephrons and/or the 
downregulation of these molecules cause the renal acidosis in CKD remains to 
be further explored.  
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Table 1.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 Baseline 48 h HCl diet 
Blood WT Cy/+ WT Cy/+ 
pH 7.45 ± 0.01 7.44 ± 0.01 7.34 ± 0.01
+++ 7.13 ± 0.00***+++ 
pCO2, mmHg 36.9 ± 1.1 31.3 ± 0.3** 30.1 ± 0.6
++ 26.3 ± 1.2*++ 
pO2, mmHg 90.9 ± 1.4 93.4 ± 1.4 96.7 ± 1.1
++ 95.3 ± 4.3 
HCO3-, mM 25.2 ± 0.7 20.6 ± 0.2*** 15.6 ± 0.3
+++ 8.3 ± 0.4***+++ 
SO2, % 95.4 ± 0.3 95.6
 ± 0.2 95.2 ± 0.1 93.3 ± 0.8* 
Hematocrit 43.9 ± 2.9 40.6 ± 2.1** 46.0 ± 0.6 37.3 ± 0.7*** 
Sodium, mM 139.0 ± 1.0 137.0 ± 0.4 145 ± 2
+ 145 ± 4+ 
Potassium, mM 3.8 ± 0.1 4.7 ± 0.1** 5.4 ± 0.2
++ 5.4 ± 0.3 
Chloride, mM 100.0 ± 1.0 103 ± 1.0* 106 ± 1***
++ 115 ± 2**+++ 
Phosphate, mg/dl 6.8 ± 0.2 7.9 ± 0.3** 6.9 ± 0.1 8.3 ± 0.4** 
Creatinine, mg/dl 0.3 ± 0.0 0.7 ± 0.0 0.3 ± 0.0 1.3 ± 0.1***
++ 
BUN, mg/dl 15 ± 1 43 ± 2*** 14 ± 1 48 ± 3*** 
Albumin, g/dl 1.8 ± 0.1 1.8 ± 0.0 1.9 ± 0.0 1.7 ± 0.1** 
Glucose, mg/dl 247 ± 18 197 ± 3* 220 ± 7 173 ± 5***
++ 
Table 2. 
 Baseline 24 h HCl diet 48 h HCl diet 
Urine WT Cy/+ WT Cy/+ WT Cy/+ 
pH 6.61 ± 0.03 5.74 ± 0.06*** 5.73 ± 0.03
+++ 5.48 ± 0.02***,++ 5.37 ± 0.03+++ 5.29 ± 0.02*,+++ 
24h urine/body weight (ml/g) 0.09 ± 0.00 0.09 ± 0.01 0.11 ± 0.02
++ 0.10 ± 0.01 0.10 ± 0.01 0.12 ± 0.00 
Creatinine clearance, ml/min 8.3 ± 0.9 2.5 ± 0.2 n/a n/a 3.68 ± 0.22
+++ 0.82 ± 0.08***,+++ 
Na+, mmol/24h 1.06 ± 0.12 1.33 ± 0.05 2.64 ± 0.17
+++ 1.22 ± 0.10*** 2.18 ± 0.06+++ 1.33 ± 0.14*** 
K+, mmol/24h 4.30 ± 0.36 6.77 ± 0.15*** 6.57 ± 0.31
+++ 5.99 ± 0.27+ 6.92 ± 0.16+++ 4.50 ± 0.29***,+++ 
Phosphate, mmol/24 h 0.63 ± 0.03 0.96 ± 0.04*** 1.05 ± 0.08
+++ 1.08 ± 0.07 1.18 ± 0.05+++ 1.27 ± 0.07++ 
NH4+, mmol/24 h 0.11 ± 0.01 0.07 ± 0.00 3.18 ± 0.22
+++ 1.10 ± 0.24***,++ 8.32 ± 0.25+++ 1.71 ± 0.09***,++ 
HCO3-, mmol/24 h 5.78 ± 0.44 1.17 ± 0.13*** 0.29 ± 0.04
+ 0.39 ± 0.03++ 0.18 ± 0.02+++ 0.22 ± 0.01+++ 
FIGURE LEGENDS 
 
Table 1  
Summary of arterial blood parameters from wildtype and cy/+ CKD rats on 
standard diet or after 2 days of HCl-diet. Values are means ± SE; n=5-6 
animals/group, *,+ p < 0.05, **,++ p < 0.01, ***,+++ p < 0.001, * significantly different 
between wildtype and CKD rats (cy/+) at the same time point, + significantly 
different between baseline and 48h HCl diet for the same genotype. 
 
Table 2  
Summary of urine parameters from wildtype and cy/+ CKD rats  on standard diet 
or after 2 days of HCl-diet. Values are means ± SE; n=3-6 animals/group, *,+ p < 
0.05, **,++ p < 0.01, ***,+++ p < 0.001, * significantly different between wildtype and 
CKD rats (cy/+) for the same time point, + significantly different between baseline 
and/or 24h HCl and/or 48h HCl diet for the same genotype. 
 
Figure 1. Reduced mRNA expression of key ammoniagenic molecules in 
kidneys from CKD rats 
Normalized mRNA abundance of PEPCK, SNAT3, PDG, and NHE3 in kidneys 
from controls and CKD rats (cy/+) under standard diet and 2 days of acid load 
with HCl. n=5-6 per group, * p < 0.05, ** p < 0.01, *** p < 0.001 significantly 
different between wildtype and CKD rats (cy/+). 
 
 
Impaired ammonium excretion in CKD 
28 
 
Figure 2. Altered expression of key molecules of ammoniagenesis in 
kidneys from CKD rats 
Protein abundance of PEPCK, SNAT3, PDG, and NHE3 are shown in controls 
and CKD rats (cy/+) on standard diet and after 2 days of acid load with HCl. The 
immunoblots were stripped and reprobed for all proteins and β-actin. All data 
were normalized against β-actin. n=5-6 per group, * p < 0.05, ** p < 0.01, *** p < 
0.001 significantly different between wildtype and CKD rats (cy/+). 
 
 
Figure 3. Altered expression of the proximal tubular bicarbonate 
transporter NBCe1 
Normalized mRNA and protein abundance of NBCe1 are shown in controls and 
CKD rats (cy/+) on standard diet and after 2 days of acid load with HCl. 
Immunoblots were normalized against β-actin. n=5-6 per group, * p < 0.05, ** p < 
0.01, *** p < 0.001 significantly different between wildtype and CKD rats (cy/+). 
 
 
Figure 4. mRNA expression of sodium dependent phosphate transporters 
is altered in CKD  rats  
Normalized mRNA abundance of NaPi-IIa, NaPi-IIc, and Pit-2 are shown in 
controls and CKD rats (cy/+) on standard diet and after 2 days of acid load with 
HCl. n=5-6 per group, * p < 0.05, ** p < 0.01, *** p < 0.001 significantly different 
between wildtype and cy/+. 
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Figure 5. Expression of renal sodium dependent phosphate transporters in 
CKD rats 
Protein abundance of NaPi-IIa, NaPi-IIc, and Pit-2 are shown in controls and 
CKD (cy/+) rats on standard diet and after 2 days of acid load with HCl. The 
immunoblots were stripped and reprobed for all proteins and β-actin. All data 
were normalized against β-actin. n=5-6 per group, * p < 0.05, ** p < 0.01, *** p < 
0.001 significantly different between wildtype and CKD rats (cy/+). 
 
 
Figure 6. Regulation of mRNA abundance of collecting duct acid-base 
transporters  
Normalized mRNA abundance of AE1, pendrin, RhCG, and B1 subunit of the H+-
ATPase are shown in controls and CKD rats (cy/+) on standard diet and after 2 
days of acid load with HCl. n=5-6 per group, * p < 0.05, ** p < 0.01, *** p < 0.001 
significantly different between wildtype and CKD rats (cy/+). 
 
 
Figure 7. Reduced expression of the ammonia transporters RhCG  
Protein abundance of AE1, pendrin, RhCG, and the B1 subunit of the H+-ATPase 
are shown in controls and CKD rats (cy/+) on standard diet and after 2 days of 
acid load with HCl. The immunoblots were stripped and reprobed for all proteins 
and β-actin. All data were normalized against β-actin. n=5-6 per group, * p < 
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0.05, ** p < 0.01, *** p < 0.001 significantly different between wildtype and CKD 
rats (cy/+). 
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Supplementary table 1. List of primary antibodies 
1° Antibody Host Dilution Source (Ref) 
β-Actin mouse 1:20000 (1) 
AE1 rabbit 1, day 115 1:10000 (2) 
Atp6v1b1 (B1) rabbit 1, day 90 1:5000 (3) 
PDG (Glutaminase) rabbit 1:5000 (4) 
NaPi-IIa rabbit 1:6000 (5) 
NaPi-IIc rabbit 1:3000 (6) 
NBCe1 rabbit SG-3341 1:10000 (7) 
NHE3 rabbit 2, day 115 1:5000 (8) 
Pendrin rabbit 1, day 115 1:5000 (9) 
PEPCK-C rabbit 1:5000 (10) 
Pit-2 rabbit 1:3000 (11) 
RhCG mouse 1:5000 (12) 
SNAT3 rabbit ~1:667 (13) 
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Supplementary table 2. Primers and probes used for semi-quantitative real-time RT-PCR 
 
Gene Acc. No. Primers Probe 
Slc4a1 (AE1) NM_012651.2 Fw: 5'-GCC ATG ATG CTA CGA AAG TTC A-3' 5'-CCT ACT TCC CCG GCA AGC TAC GCA G-3' 
  
Rev: 5'-GGA CCA TTA TCA GGA TGG AGA TG-3' 
 Atp6v1b1 (B1) NM_001107867.2 Fw: 5'-GTC AAT GGG CCT CTG GTG-3' 5'-CTC AGA GGA GTG GCC AAG TGC TTG A-3' 
  
Rev: 5'-CCC TCA AAC ACC TGA ACA ATG-3' 
 PDG (Glutaminase) NM_012569.2 Fw: 5'-CTT CTC AGG GCA GTT TGC ATT-3' 5'-CTT CCT GCA AAA TCT GGA GTT GCT GGG-3' 
  
Rev: 5'-TTC CTT TAA CAC TGT TGC CCA TCT-3' 
 Slc34a1 (NaPi-IIa) NM_013030.1 Fw: 5'-GGA ATC ACA GTC TCA TTC GGA TT-3' 5'-TGT CAA CCA GAG ACA AAA GAG GCT TCC ACT-3' 
  
Rev: 5'-ATG GCC TCT ACC CTG GAC ATA G-3' 
 Slc34a3 (NaPi-IIc) NM_139338.1 Fw: 5'-GGG ATC GGG ATG AAT TTC AGA-3' 5'-ACG GCA TCT TCA ACT GGC TCA CAG TGT T-3' 
  
Rev: 5'-GGG CCA GCT CAC TCA GTC TCT-3' 
 Slc4a4A+B (NBCe1) NM_053424.1 Fw: 5'-GGT GTG GAT ACT CCG AAG CTA ATT-3' 5'-AGT TCA AGC CAA CAA GCC CTC ACC G-3' 
  
Rev: 5'-CAA AGG GTG GGA CAA ACC AA-3' 
 Slc9a3 (NHE3) NM_012654.1 Fw: 5'-CAC CCA CCA CAC GTT GCA-3' 5'-CTC TAC AAG CCT CGG CAG GAG TAC AA-3' 
  
Rev: 5'-GTG AGC TCG TGC CGA CTG T-3' 
 Slc26a4 (Pendrin) NM_019214.1 Fw: 5'-CGC CAC CAA GCA TGA CTA CA-3' 5'-AAC CAG GAA TTC ATT GCC TTC GGG ATA A-3' 
  
Rev: 5'-TCC TGG ACA GCC GTT CGA-3' 
 Pck1 (PEPCK-C) NM_198780.3 Fw: 5'-AGT CAC CAT CAC TTC CTG GAA GA-3' 5'-AGT GGA GAC CAC AGG ATG AGG AAC CGT-3' 
  
Rev: 5'-GGT GCA GAA TCG CGA GTT G-3' 
 Slc20a2 (Pit-2) NM_017223.2 Fw: 5'-CCT GCT TTG GGT CCT TTG C-3' 5'-ACG GTG GCA ACG ATG TGA GCA ATG-3' 
  
Rev: 5'-CAG CCA CAG GGC CAC AAG-3' 
 Rhcg (RhCG) NM_183053.1 Fw: 5'-CTC CTT GGC AGC TAG TGT GCT A-3' 5'-AAG AAG GGC AAG TTG GAT ATG GTG CAC A-3' 
  
Rev: 5'-CCT GCA AGT GTG GCG TTC T-3' 
 Slc38a3 (SNAT3) NM_145776.1 Fw: 5'-CCT GAG GTG CTG CCC ATA TAT AC-3' 5'-TCA AGG ACC CCT CCA AGA GGA AGA TGC-3' 
  
Rev: 5'-GCA ATG GAC AGG TTG GAG ATG-3' 
 18S rRNA 4310893E Applied Biosystems 
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